https://www.selleckchem.com/pr....oducts/lithocholic-a
Participants with past-month injecting drug use (OR 0.23; 95%CI 0.09-0.61) or heroin use (OR 0.23; 95%CI 0.08-0.65) at baseline had lower odds of being retained in treatment to 48 weeks. Reductions in multiple forms of extra-medical drug use were observed. Improvements in quality of life, participation in employment, and treatment satisfaction measures were also observed. This real-world implementation study of BUP-XR demonstrated high retention and treatment satisfaction. This study provides important additional data on the up
Like
Comment
Share
